SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-15-000110
Filing Date
2015-11-09
Accepted
2015-11-09 17:26:11
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-9301510q.htm 10-Q 1047958
2 EXHIBIT 10.1 ligand-amendmentno4tosubli.htm EX-10.1 50011
3 EXHIBIT 31.1 lgnd_93015exhibit311.htm EX-31.1 16301
4 EXHIBIT 31.2 lgnd_93015exhibit312.htm EX-31.2 16198
5 EXHIBIT 32.1 lgnd_93015exhibit321.htm EX-32.1 15521
  Complete submission text file 0000886163-15-000110.txt   7696795

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20150930.xml EX-101.INS 1743893
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20150930.xsd EX-101.SCH 49655
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20150930_cal.xml EX-101.CAL 93690
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20150930_def.xml EX-101.DEF 279723
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20150930_lab.xml EX-101.LAB 822069
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20150930_pre.xml EX-101.PRE 446460
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 151216803
SIC: 2834 Pharmaceutical Preparations